These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12819316)

  • 1. A comprehensive public health approach to address the burden of renal disease in singapore.
    Ramirez SP
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S122-6. PubMed ID: 12819316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking a public health approach to the prevention of end-stage renal disease: the NKF Singapore Program.
    Ramirez SP; Hsu SI; McClellan W
    Kidney Int Suppl; 2003 Feb; (83):S61-5. PubMed ID: 12864877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease prevention in Singapore.
    Ramirez SP
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):610-5. PubMed ID: 18184881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for chronic kidney disease: unresolved issues.
    McClellan WM; Ramirez SP; Jurkovitz C
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S81-7. PubMed ID: 12819308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Study of the National Kidney Foundation's (NKF) Kidney Early Evaluation Program (KEEP).
    Ohmit SE; Flack JM; Peters RM; Brown WW; Grimm R
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S117-21. PubMed ID: 12819315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia.
    Perico N; Plata R; Anabaya A; Codreanu I; Schieppati A; Ruggenenti P; Remuzzi G
    Kidney Int Suppl; 2005 Aug; (97):S87-94. PubMed ID: 16014107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary health care strategies for the prevention of end-stage renal disease in Cuba.
    Almaguer M; Herrera R; Alfonso J; Magrans C; Mañalich R; Martínez A
    Kidney Int Suppl; 2005 Aug; (97):S4-10. PubMed ID: 16014098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the prevention of chronic kidney disease in Latin America.
    Rodríguez-Iturbe B
    Nat Clin Pract Nephrol; 2008 May; 4(5):233. PubMed ID: 18432210
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic kidney disease in Cuba: epidemiological studies, integral medical care, and strategies for prevention.
    Almaguer M; Herrera R; Alfonzo J; Magrans C; Mañalich R; Martinez A; Davalos J; Perez-Oliva J; Landrove O
    Ren Fail; 2006; 28(8):671-6. PubMed ID: 17162425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease awareness, screening and prevention: rationale for the design of a public education program.
    Collins AJ; Gilbertson DT; Snyder JJ; Chen SC; Foley RN
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():37-42. PubMed ID: 20586946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan.
    Hwang SJ; Tsai JC; Chen HC
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():3-9. PubMed ID: 20586940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESRD in Guatemala and a model for preventive strategies: outlook of the Guatemalan Foundation for Children with Kidney Diseases.
    Lou-Meda R
    Ren Fail; 2006; 28(8):689-91. PubMed ID: 17162427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradigms of public-private partnerships in end-stage renal disease care: the National Kidney Foundation Singapore.
    Ramirez SP; Durai TT; Hsu SI
    Kidney Int Suppl; 2003 Feb; (83):S101-7. PubMed ID: 12864885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of the progression of chronic kidney disease: practice in China.
    Wang H; Zhang L; Lv J
    Kidney Int Suppl; 2005 Apr; (94):S63-7. PubMed ID: 15752243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Kidney Disease Education Program.
    Hostetter TH; Lising M
    J Natl Med Assoc; 2002 Aug; 94(8 Suppl):72S-75S. PubMed ID: 12152915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening populations at increased risk of CKD: the Kidney Early Evaluation Program (KEEP) and the public health problem.
    Vassalotti JA; Li S; Chen SC; Collins AJ
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S107-14. PubMed ID: 19231754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective.
    Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2017 Nov; 55(9):956-969. PubMed ID: 28644057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and renal dysfunction: NHANES III.
    Jones CA
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S71-5. PubMed ID: 12819306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression, remission, regression of chronic renal diseases.
    Ruggenenti P; Schieppati A; Remuzzi G
    Lancet; 2001 May; 357(9268):1601-8. PubMed ID: 11377666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing the Global Kidney Disease Prevention Network (KDPN): a position statement from the National Kidney Foundation.
    Obrador GT; Mahdavi-Mazdeh M; Collins AJ;
    Am J Kidney Dis; 2011 Mar; 57(3):361-70. PubMed ID: 21335246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.